<DOC>
	<DOCNO>NCT00235833</DOCNO>
	<brief_summary>The purpose study ass long-term safety , tolerability , efficacy repeat administration adalimumab adult Japanese subject rheumatoid arthritis .</brief_summary>
	<brief_title>Adalimumab Adult Japanese Subjects With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Participation prior adalimumab study Body weight less 100 kg . Subject 's wished continue study drug administration Females must postmenopausal least 1 year , surgically sterile , practice birth control throughout study 90 day study completion . A subject experience follow prior adalimumab sc dose study : Advanced poorly control diabetes Any poorly control medical condition Intraarticular , intramuscular iv administration corticosteroid Joint surgery . A subject prescribed exclude medication previous adalimumab study . History clinically significant drug alcohol abuse , intravenous ( iv ) drug abuse , active infection listeria tuberculosis ( TB ) , lymphoma , leukemia , malignancy exception successfully treat non metastatic basal cell carcinoma skin . A subject experience chronic active infection major episode infection require hospitalization treatment intravenous ( iv ) antibiotic within 30 day entry study chronic use oral antibiotic within 14 day entry study . Preexisting recent onset central nervous system ( CNS ) demyelinate disorder .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
</DOC>